About GNINE Bioceuticals
GNINE Bioceuticals is a Healthcare company based in Karnal (India) founded in 2011. Manufacturing of pharmaceutical formulations and veterinary products in India. The company has 8 employees. Its Indian entity G Nine Bioceuticals Private Limited reported revenue of ₹19.42 Cr. GNINE Bioceuticals offers products and services including Tablets and Injectables. Its focus areas include Veterinary, Animal Health, Veterinary Pharmaceuticals and Pharmaceuticals.
Company details
GNINE Bioceuticals is identified as an ISO 9001-2015 certified entity that produces pharmaceutical formulations, with a specialization in antibiotics within the Beta Lactam section. It operates from a WHO-GMP compliant facility in Karnal, Haryana, India, which meets Schedule M standards and supports third-party manufacturing for various clients. Quality control is emphasized through advanced labs, and production includes tablets, dry syrups, and injectables for both human and veterinary markets, ensuring adherence to global norms and timely order fulfillment. This commitment to quality and care has been demonstrated over more than 25 years in the industry.
- Headquarters Karnal, India
- Employees 8
- SectorsHealthcare
- Email••••••••
- Website gninebio.com
- Legal Name G Nine Bioceuticals Pvt. Ltd
- Date of Incorporation 19 Aug, 2008
- Jurisdiction Karnal, Haryana, India
- Annual Revenue₹19.42 Cr
FY 2025 · +5% YoY
- Net Profit₹57.3 Lakh
FY 2025 · 3% margin
- EBITDA₹1.27 Cr
FY 2025 · 7% margin
- Employee Count8
Associated legal entities of GNINE Bioceuticals
GNINE Bioceuticals operates through G Nine Bioceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| G Nine Bioceuticals Private Limited CIN U74900HR2008PTC038275 | Active | 19 Aug 2008 | Karnal, Haryana | ₹19.4 Cr | 8 | 2 | View details |
Products & Services of GNINE Bioceuticals
GNINE Bioceuticals offers a comprehensive portfolio of products and services, including Tablets and Injectables.
Tablets are manufactured for human and veterinary applications, primarily in the antibiotics sector.
Injectables are produced for both human and veterinary use, adhering to international quality standards.
Board of directors of G Nine Bioceuticals Private Limited (GNINE Bioceuticals)
G Nine Bioceuticals Private Limited is the primary company behind GNINE Bioceuticals. The board of G Nine Bioceuticals Private Limited currently have 2 directors; the longest-serving is Narender Arora, appointed in 2008. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Narender Arora DIN 02227276 | Director | 19 Aug 2008 | 18 yrs 2 mo | G Nine Bioceuticals Private Limited |
| Robin DIN 08776031 | Director | 02 Jul 2020 | 6 yrs 4 mo | G Nine Bioceuticals Private Limited |
Financials of GNINE Bioceuticals
Figures of G Nine Bioceuticals Private Limited, the primary company behind GNINE Bioceuticals, for FY 2025. Revenue was ₹19.42 Cr (+5% year on year). Net profit was ₹57.3 Lakh (3% margin). EBITDA was ₹1.27 Cr (7% margin). Revenue has grown at a compounded annual rate of +3% over three years and +8% over five years.
- ₹19.42 CrRevenue · FY 2025 · +5% YoY
- ₹57.3 LakhNet profit · 3% margin
- ₹1.27 CrEBITDA · 7% margin
- ₹81.8 LakhPaid-up capital
- 8Employees (provident fund records)
- +3%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of G Nine Bioceuticals Private Limited are on its company page.
Detailed financial statements for GNINE Bioceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GNINE Bioceuticals
GNINE Bioceuticals was founded in 2011.
GNINE Bioceuticals is headquartered in Karnal, India. It is registered at Karnal, Haryana, India.
GNINE Bioceuticals has 8 employees.
The primary company behind GNINE Bioceuticals, G Nine Bioceuticals Private Limited, reported revenue of ₹19.42 Cr for FY 2025, up 5% year on year.
GNINE Bioceuticals is identified as an ISO 9001-2015 certified entity that produces pharmaceutical formulations, with a specialization in antibiotics within the Beta Lactam section. It operates from a WHO-GMP compliant facility in Karnal, Haryana, India, which meets Schedule M standards and supports third-party manufacturing for various clients. Quality control is emphasized through advanced labs, and production includes tablets, dry syrups, and injectables for both human and veterinary markets, ensuring adherence to global norms and timely order fulfillment. This commitment to quality and care has been demonstrated over more than 25 years in the industry.
GNINE Bioceuticals offers Tablets and Injectables.
GNINE Bioceuticals operates through G Nine Bioceuticals Private Limited.
The legal entities of GNINE Bioceuticals currently have 2 directors, including Robin, Narender Arora.